Sensing damage by the NLRP3 inflammasome
- 26 August 2011
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 243 (1), 152-162
- https://doi.org/10.1111/j.1600-065x.2011.01043.x
Abstract
Summary: The NLRP3 inflammasome is activated in response to a variety of signals that are indicative of damage to the host including tissue damage, metabolic stress, and infection. Upon activation, the NLRP3 inflammasome serves as a platform for activation of the cysteine protease caspase‐1, which leads to the processing and secretion of the proinflammatory cytokines interleukin‐1β (IL‐1β) and IL‐18. Dysregulated NLRP3 inflammasome activation is associated with both heritable and acquired inflammatory diseases. Here, we review new insights into the mechanism of NLRP3 inflammasome activation and its role in disease pathogenesis.Keywords
This publication has 100 references indexed in Scilit:
- Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasomeCell Death & Disease, 2011
- The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin SensitivityCell Metabolism, 2010
- Why not treat human cancer with interleukin-1 blockade?Cancer and Metastasis Reviews, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Sensing pathogens and danger signals by the inflammasomeCurrent Opinion in Immunology, 2009
- Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellinNature Immunology, 2008
- The Nlrp3 inflammasome is critical for aluminium hydroxide‐mediated IL‐1β secretion but dispensable for adjuvant activityEuropean Journal of Immunology, 2008
- The NALP3 inflammasome is involved in the innate immune response to amyloid-βNature Immunology, 2008
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology, 2008
- Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s diseaseNature, 2008